Matches in SemOpenAlex for { <https://semopenalex.org/work/W2015041805> ?p ?o ?g. }
- W2015041805 endingPage "834" @default.
- W2015041805 startingPage "829" @default.
- W2015041805 abstract "To compare the effectiveness, safety and tolerability of sildenafil and apomorphine in Brazilian patients with erectile dysfunction (ED) of various causes.In all, 108 patients (mean age 55 years, sd 11) and documented ED for > or =6 months were included in 12 centres in Brazil. The patients were initially followed for 2 weeks and then randomized to initial treatment with apomorphine or sildenafil, taken before sexual intercourse, no more than once a day. The initial dose (2 mg apomorphine and 50 mg sildenafil) could be adjusted (to 3 mg apomorphine, or to 25 or 100 mg for sildenafil) depending on the effectiveness and tolerability during the first 4 weeks of treatment. The patients were re-evaluated after 8 weeks on treatment and, after a wash-out period of 2 weeks (no treatment), received the other study drug (other than that received in the first phase), and then had the same procedures as in the first phase.In all, 97 patients were evaluated for therapeutic effectiveness, the overall effectiveness being assessed using two questions; sildenafil had a significantly higher proportion of affirmative answers for both (P < 0.001). Likewise, the estimates for the mean (sd) proportion of successful sexual intercourse, of 83.3 (4.7)% vs 40.3 (4.7)% and the total ED Inventory of Treatment Satisfaction score, of 86.7 (2.9) vs 56.9 (2.9) (P < 0.001) were higher for sildenafil. At the end of the study, 93.8% of the patients randomized to initial therapy with apomorphine declared a preference for sildenafil, and 81.3% of those initially treated with sildenafil declared a preference for that drug. The two drugs were well tolerated, and the main adverse events for apomorphine were nausea, vomiting, headache, taste perversion and dizziness; for sildenafil they were headache, flushing or vasodilatation, abdominal pain or dyspepsia and nasal congestion.Sildenafil is more effective than apomorphine for treating ED, in the domains of erectile function, satisfaction with sexual intercourse and overall satisfaction, and was the drug preferred by most of the patients." @default.
- W2015041805 created "2016-06-24" @default.
- W2015041805 creator A5004076063 @default.
- W2015041805 creator A5026494399 @default.
- W2015041805 creator A5029881582 @default.
- W2015041805 creator A5033199740 @default.
- W2015041805 creator A5033438553 @default.
- W2015041805 creator A5040364769 @default.
- W2015041805 creator A5053963774 @default.
- W2015041805 creator A5057882286 @default.
- W2015041805 creator A5059398099 @default.
- W2015041805 creator A5069789449 @default.
- W2015041805 creator A5087663727 @default.
- W2015041805 creator A5090648799 @default.
- W2015041805 date "2008-10-01" @default.
- W2015041805 modified "2023-10-17" @default.
- W2015041805 title "Comparative cross-over study of sildenafil and apomorphine for treating erectile dysfunction" @default.
- W2015041805 cites W1576608716 @default.
- W2015041805 cites W1979438300 @default.
- W2015041805 cites W1989118700 @default.
- W2015041805 cites W1989446771 @default.
- W2015041805 cites W1999059326 @default.
- W2015041805 cites W2005841974 @default.
- W2015041805 cites W2007712016 @default.
- W2015041805 cites W2028111681 @default.
- W2015041805 cites W2034107299 @default.
- W2015041805 cites W2035181223 @default.
- W2015041805 cites W2035472660 @default.
- W2015041805 cites W2044156754 @default.
- W2015041805 cites W2049055260 @default.
- W2015041805 cites W2052518051 @default.
- W2015041805 cites W2055698659 @default.
- W2015041805 cites W2088481256 @default.
- W2015041805 cites W2091416414 @default.
- W2015041805 cites W2122207413 @default.
- W2015041805 cites W2131925302 @default.
- W2015041805 cites W2144176616 @default.
- W2015041805 cites W2164189667 @default.
- W2015041805 cites W22857079 @default.
- W2015041805 cites W2297358297 @default.
- W2015041805 cites W2328280790 @default.
- W2015041805 cites W3203428157 @default.
- W2015041805 cites W4243770305 @default.
- W2015041805 doi "https://doi.org/10.1111/j.1464-410x.2008.07767.x" @default.
- W2015041805 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18537952" @default.
- W2015041805 hasPublicationYear "2008" @default.
- W2015041805 type Work @default.
- W2015041805 sameAs 2015041805 @default.
- W2015041805 citedByCount "10" @default.
- W2015041805 countsByYear W20150418052012 @default.
- W2015041805 countsByYear W20150418052015 @default.
- W2015041805 countsByYear W20150418052019 @default.
- W2015041805 countsByYear W20150418052020 @default.
- W2015041805 crossrefType "journal-article" @default.
- W2015041805 hasAuthorship W2015041805A5004076063 @default.
- W2015041805 hasAuthorship W2015041805A5026494399 @default.
- W2015041805 hasAuthorship W2015041805A5029881582 @default.
- W2015041805 hasAuthorship W2015041805A5033199740 @default.
- W2015041805 hasAuthorship W2015041805A5033438553 @default.
- W2015041805 hasAuthorship W2015041805A5040364769 @default.
- W2015041805 hasAuthorship W2015041805A5053963774 @default.
- W2015041805 hasAuthorship W2015041805A5057882286 @default.
- W2015041805 hasAuthorship W2015041805A5059398099 @default.
- W2015041805 hasAuthorship W2015041805A5069789449 @default.
- W2015041805 hasAuthorship W2015041805A5087663727 @default.
- W2015041805 hasAuthorship W2015041805A5090648799 @default.
- W2015041805 hasBestOaLocation W20150418051 @default.
- W2015041805 hasConcept C126322002 @default.
- W2015041805 hasConcept C126894567 @default.
- W2015041805 hasConcept C141071460 @default.
- W2015041805 hasConcept C168563851 @default.
- W2015041805 hasConcept C170493617 @default.
- W2015041805 hasConcept C197934379 @default.
- W2015041805 hasConcept C2776768464 @default.
- W2015041805 hasConcept C2777525119 @default.
- W2015041805 hasConcept C2778093883 @default.
- W2015041805 hasConcept C2778375690 @default.
- W2015041805 hasConcept C2778938600 @default.
- W2015041805 hasConcept C2779929075 @default.
- W2015041805 hasConcept C2780202899 @default.
- W2015041805 hasConcept C2908647359 @default.
- W2015041805 hasConcept C42219234 @default.
- W2015041805 hasConcept C71924100 @default.
- W2015041805 hasConcept C99454951 @default.
- W2015041805 hasConceptScore W2015041805C126322002 @default.
- W2015041805 hasConceptScore W2015041805C126894567 @default.
- W2015041805 hasConceptScore W2015041805C141071460 @default.
- W2015041805 hasConceptScore W2015041805C168563851 @default.
- W2015041805 hasConceptScore W2015041805C170493617 @default.
- W2015041805 hasConceptScore W2015041805C197934379 @default.
- W2015041805 hasConceptScore W2015041805C2776768464 @default.
- W2015041805 hasConceptScore W2015041805C2777525119 @default.
- W2015041805 hasConceptScore W2015041805C2778093883 @default.
- W2015041805 hasConceptScore W2015041805C2778375690 @default.
- W2015041805 hasConceptScore W2015041805C2778938600 @default.
- W2015041805 hasConceptScore W2015041805C2779929075 @default.
- W2015041805 hasConceptScore W2015041805C2780202899 @default.
- W2015041805 hasConceptScore W2015041805C2908647359 @default.